SCHEMBL19081129

SCHEMBL19081129

CC1(C)c2ccc3ccccc3c2-c2c1ccc1c2sc2cc(-c3c4ccccc4c(-c4cccc(-c5ccc6ccccc6c5)c4)c4ccccc34)ccc21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
HSD17B1 P14061 3/20 0.32
HSD17B2 P37059 3/20 0.32
LIMK1 P53667 3/20 0.31
CYP1A2 P05177 3/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2B6 P20813 2/20 0.31
CYP2C19 P33261 2/20 0.31
LIMK2 P53671 1/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31
CHRNA3 P32297 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081094 0.96 CYP1A1 (0.31) CYP1A1CYP1B1CYP1A2LPLLIPG
SCHEMBL19081246 0.93 F9 (0.32) CYP1A1CYP1B1HSD17B1HSD17B2CYP1A2
SCHEMBL18842985 0.90 ALOX5 (0.33) HSD17B1HSD17B2LIMK1CHRNA1CHRNG
SCHEMBL17945762 0.90 ALOX5 (0.33) HSD17B1HSD17B2LIMK1CHRNA1CHRNG
SCHEMBL19081131 0.89 CYP1A1 (0.31) CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL17945139 0.86 ALOX5 (0.36) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL19081144 0.85 F9 (0.33) CYP1A1CYP1B1LIMK1F9MCL1
SCHEMBL19081127 0.85 HSD17B1 (0.31) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL19081128 0.85 HSD17B1 (0.31) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL19081095 0.85 ALOX5 (0.32) CYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885HSD17B1 1146/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885HSD17B1 1146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.